[Hematopoietic cell death and leukemia]

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Context:

• Leukemogenesis is a multistep process driven by genetic alterations affecting protein function.
• These alterations disrupt the balance of cell proliferation, differentiation, and programmed cell death (PCD).
• Apoptosis (Type I PCD) and autophagy (Type II PCD) are crucial intracellular processes for cell homeostasis.

Purpose:

• To elucidate the complex mechanisms of apoptosis and autophagy in leukemia cells.
• To identify the obscure molecular machinery regulating these cell death pathways.
• To provide a foundation for developing novel therapeutic strategies for leukemia.

Summary:

• Leukemogenesis involves genetic mutations that dysregulate cell death pathways, leading to malignant cell expansion.
• Apoptosis and autophagy, key forms of programmed cell death, are complex and poorly understood in leukemia.
• Investigating these pathways is vital for advancing leukemia treatment.

Impact:

• Enhanced understanding of apoptotic and autophagic signaling in leukemia.
• Potential identification of new therapeutic targets for leukemia treatment.
• Improved strategies for managing leukemia through cell death pathway modulation.